Cargando…

The status and progress of first-line treatment against Helicobacter pylori infection: a review

Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP is also engaged in the development of gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. It is an important pathogenic factor in various other systemic diseases, such as vitamin B12 defi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Caiqi, Wang, Yuan, Shi, Jiaqi, Zhang, Chunhui, Nie, Jianhua, Li, Shun, Zheng, Tongsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243100/ https://www.ncbi.nlm.nih.gov/pubmed/34262609 http://dx.doi.org/10.1177/1756284821989177

Ejemplares similares

Current Status of the Third-Line Helicobacter pylori Eradication
por: Choi, Jae Ho, et al.
Publicado: (2018)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
por: Tariq, Hassan, et al.
Publicado: (2020)

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012)

Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies
por: Lee, Ju Yup, et al.
Publicado: (2016)

Adapted first-line treatment of Helicobacter pylori infection in Algerian children
por: Moubri, Mostefa, et al.
Publicado: (2019)

Dimethylaminododecyl Methacrylate-Incorporated Dental Materials Could Be the First Line of Defense against Helicobacter pylori
por: Chen, Xi, et al.
Publicado: (2023)

Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori
por: Tamene, Yonas, et al.
Publicado: (2023)

A Study of the S-1 or Capecitabine as First-line Regimen in Patients with Metastatic Colorectal Cancer: A Real World Study
por: Guo, Yanan, et al.
Publicado: (2020)

Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection
por: Bang, Chang Seok, et al.
Publicado: (2015)

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
por: Kwack, WonGun, et al.
Publicado: (2016)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
por: Ierardi, Enzo, et al.
Publicado: (2017)

Recent progress in Helicobacter pylori treatment
por: Hu, Yi, et al.
Publicado: (2020)

GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS
por: RAMZY, Iman, et al.
Publicado: (2016)

Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances
por: Shih, Chih-An, et al.
Publicado: (2022)

A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
por: Nie, Jianhua, et al.
Publicado: (2021)

Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection
por: Xue, Ruo-Yi, et al.
Publicado: (2019)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective
por: Miftahussurur, Muhammad, et al.
Publicado: (2015)

First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
por: De Francesco, Vincenzo, et al.
Publicado: (2017)

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
por: Caldas, María, et al.
Publicado: (2020)

Status of vaccine research and development for Helicobacter pylori
por: Sutton, Philip, et al.
Publicado: (2019)

Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis
por: Perry, Sharon, et al.
Publicado: (2010)

Genetics of Host Protection against Helicobacter pylori Infections
por: Capparelli, Rosanna, et al.
Publicado: (2021)

Antimicrobial Effects of Lactoferrin against Helicobacter pylori Infection
por: Imoto, Ichiro, et al.
Publicado: (2023)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy
por: Huang, Chih-Chieh, et al.
Publicado: (2017)

Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis
por: Sugimoto, Mitsushige, et al.
Publicado: (2018)

Effect of Helicobacter Pylori Infection on Nutritional Status in Polish Teenagers
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2021)

Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
por: Song, Zifan, et al.
Publicado: (2020)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Protocol for the identification and expression analysis of a cytoplasmic membrane-localized protein STING
por: Shi, Jiaqi, et al.
Publicado: (2023)

β-Defensins in the Fight against Helicobacter pylori
por: Pero, Raffaela, et al.
Publicado: (2017)

Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection
por: Yang, Jyh-Chin, et al.
Publicado: (2013)

Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis
por: Shen, Huili, et al.
Publicado: (2022)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy
por: Deguchi, Ryuzo, et al.
Publicado: (2012)

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
por: Jung, Sung Min, et al.
Publicado: (2016)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lud9vs11h3c03lbgt35c51pt9u